SCHEMBL25015682

SCHEMBL25015682

CCCc1ccc(Oc2ccc(Cl)cc2)nc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.49
RAB9A P51151 1/20 0.49
ACACB O00763 2/20 0.42
HTT P42858 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42
HAO1 Q9UJM8 1/20 0.41
CYP3A4 P08684 1/20 0.41
KDM4E B2RXH2 1/20 0.41
P2RX3 P56373 8/20 0.41
HRH3 Q9Y5N1 1/20 0.41
LIPE Q05469 1/20 0.40
EGLN1 Q9GZT9 1/20 0.40
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13181088 0.91 ALDH1A1 (0.52) ALDH1A1RAB9AACACBPPARGPPARA
SCHEMBL14349927 0.87 P2RX3 (0.48) HTTL3MBTL1HAO1KDM4EP2RX3
SCHEMBL27691056 0.86 L3MBTL1 (0.43) ALDH1A1HTTL3MBTL1HAO1CYP3A4
SCHEMBL8515025 0.84 MEN1 (0.55) ALDH1A1RAB9AACACBHTTL3MBTL1
SCHEMBL15685061 0.84 MAOB (0.55) RAB9AHTTL3MBTL1HAO1KDM4E
SCHEMBL18798976 0.84 THRB (0.50) ALDH1A1RAB9AACACBL3MBTL1KDM4E
SCHEMBL15177164 0.84 ACACB (0.47) ACACBOPRM1OPRD1OPRK1
SCHEMBL9045495 0.84 OPRM1 (0.45) KDM4EP2RX3OPRM1OPRD1OPRK1
SCHEMBL23252933 0.84 TAAR1 (0.56) ACACBCYP3A4P2RX3OPRM1OPRD1
SCHEMBL9829679 0.82 L3MBTL1 (0.45) ALDH1A1HTTL3MBTL1HAO1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF MMP7, MATR3, SPINT2 ALDH1A1 3877/4885RAB9A 4274/4885ACACB 1507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.